SNGX
Price
$2.18
Change
+$0.11 (+5.31%)
Updated
Apr 24, 02:47 PM (EDT)
Capitalization
6.52M
VRAX
Price
$1.07
Change
+$0.05 (+4.90%)
Updated
Apr 24, 02:41 PM (EDT)
Capitalization
4.43M
Ad is loading...

SNGX vs VRAX

Header iconSNGX vs VRAX Comparison
Open Charts SNGX vs VRAXBanner chart's image
Soligenix
Price$2.18
Change+$0.11 (+5.31%)
Volume$1.1K
Capitalization6.52M
Virax Biolabs Group
Price$1.07
Change+$0.05 (+4.90%)
Volume$200
Capitalization4.43M
SNGX vs VRAX Comparison Chart
Loading...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNGX vs. VRAX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNGX is a Hold and VRAX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (SNGX: $2.07 vs. VRAX: $1.02)
Brand notoriety: SNGX and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNGX: 20% vs. VRAX: 21%
Market capitalization -- SNGX: $6.52M vs. VRAX: $4.43M
SNGX [@Biotechnology] is valued at $6.52M. VRAX’s [@Biotechnology] market capitalization is $4.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNGX’s FA Score shows that 1 FA rating(s) are green whileVRAX’s FA Score has 1 green FA rating(s).

  • SNGX’s FA Score: 1 green, 4 red.
  • VRAX’s FA Score: 1 green, 4 red.
According to our system of comparison, VRAX is a better buy in the long-term than SNGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNGX’s TA Score shows that 5 TA indicator(s) are bullish while VRAX’s TA Score has 6 bullish TA indicator(s).

  • SNGX’s TA Score: 5 bullish, 4 bearish.
  • VRAX’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, VRAX is a better buy in the short-term than SNGX.

Price Growth

SNGX (@Biotechnology) experienced а +0.49% price change this week, while VRAX (@Biotechnology) price change was -0.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

SNGX is expected to report earnings on May 12, 2023.

VRAX is expected to report earnings on Aug 12, 2022.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNGX($6.52M) has a higher market cap than VRAX($4.43M). SNGX YTD gains are higher at: -23.191 vs. VRAX (-54.667). VRAX has higher annual earnings (EBITDA): -6.43M vs. SNGX (-8.06M). SNGX has more cash in the bank: 9.84M vs. VRAX (7.29M). VRAX has less debt than SNGX: VRAX (380K) vs SNGX (2.2M). VRAX has higher revenues than SNGX: VRAX (84.9K) vs SNGX (0).
SNGXVRAXSNGX / VRAX
Capitalization6.52M4.43M147%
EBITDA-8.06M-6.43M125%
Gain YTD-23.191-54.66742%
P/E RatioN/AN/A-
Revenue084.9K-
Total Cash9.84M7.29M135%
Total Debt2.2M380K580%
FUNDAMENTALS RATINGS
SNGX: Fundamental Ratings
SNGX
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SNGXVRAX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
SNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REPL8.830.12
+1.38%
Replimune Group
ICFI84.52-0.64
-0.75%
ICF International
ELMD22.81-0.18
-0.78%
Electromed
GFI22.20-1.19
-5.09%
Gold Fields Ltd
GDC2.07-0.16
-7.17%
GD Culture Group Limited

SNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNGX has been loosely correlated with THAR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SNGX jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNGX
1D Price
Change %
SNGX100%
+0.24%
THAR - SNGX
46%
Loosely correlated
+3.03%
QURE - SNGX
37%
Loosely correlated
N/A
VRAX - SNGX
36%
Loosely correlated
+6.34%
ATHA - SNGX
31%
Poorly correlated
+4.91%
VNDA - SNGX
30%
Poorly correlated
-1.81%
More

VRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRAX has been loosely correlated with ALZN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VRAX jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRAX
1D Price
Change %
VRAX100%
+6.34%
ALZN - VRAX
41%
Loosely correlated
N/A
SNGX - VRAX
36%
Loosely correlated
+0.24%
NCNA - VRAX
35%
Loosely correlated
+14.09%
NTRB - VRAX
31%
Poorly correlated
+3.36%
GOVX - VRAX
31%
Poorly correlated
+3.39%
More